Media coverage
1
Media coverage
Title PR Newswire Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole Media name/outlet The Business Journals Country/Territory United States Date 20/02/19 URL https://www.bizjournals.com/prnewswire/press_releases/2019/02/20/NE58812 Persons Sanjay Mathew